Tyrosinekinase inhibition facilitates cooperation of transcription factor SALL4 and ABC transporter A3 towards intrinsic CML cell drug resistance-Reference-Cited by-同舟云学术

Tyrosinekinase inhibition facilitates cooperation of transcription factor SALL4 and ABC transporter A3 towards intrinsic CML cell drug resistance

Published:2013-02-21 Issue:2 Volume:161 Page:204-213
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Hupfeld Timo¹,Chapuy Bjoern¹,Schrader Verena¹,Beutler Markus¹,Veltkamp Christian¹,Koch Raphael¹,Cameron Silke²,Aung Thiha¹,Haase Detlef¹,LaRosee Paul³,Truemper Lorenz¹,Wulf Gerald G.¹

Affiliation:

1. Department of Haematology and Oncology; Georg-August-University Goettingen; Goettingen; Germany

2. Department of Gastroenterology and Endocrinology; Georg-August-University Goettingen; Goettingen; Germany

3. Clinic for Internal Medicine II; Department of Haematology and Oncology; University Hospital Jena; Jena; Germany

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12246/fullpdf

Reference39 articles.

1. Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3;Aung;Proc Natl Acad Sci U S A,2011

2. Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features;Avanzi;British Journal of Haematology,1988

3. Sterol response element binding protein and thyroid transcription factor-1 (Nkx2.1) regulate Abca3 gene expression;Besnard;Am J Physiol Lung Cell Mol Physiol,2007

4. Persistence of malignant haematopoietic progenitors in chronic myelogenous leukaemia patients in complete cytogenetic remission following imatinib mesylate treatment;Bhatia;Blood,2003

5. Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump;Burger;Blood,2004

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transporter-Mediated Cellular Distribution of Tyrosine Kinase Inhibitors as a Potential Resistance Mechanism in Chronic Myeloid Leukemia;Pharmaceutics;2023-10-26

2. The new advance of SALL4 in cancer: Function, regulation, and implication;Journal of Clinical Laboratory Analysis;2023-05

3. What Is the Significance of Lysosomal-Mediated Resistance to Imatinib?;Cells;2023-02-23

4. SALL4: An Intriguing Therapeutic Target in Cancer Treatment;Cells;2022-08-20

5. A curated binary pattern multitarget dataset of focused ATP-binding cassette transporter inhibitors;Scientific Data;2022-07-26